CDIO 8-K — Smart Summary

Cardio Diagnostics Holdings, Inc. held its annual meeting of stockholders on November 15, 2024, at which 14,116,148 shares (approximately 55.51% of the 25,905,656 eligible shares) were represented. Stockholders voted on four proposals: election of seven directors, a reverse stock split amendment, a share issuance approval, and ratification of the independent auditor.

• Meeshanthini Dogan, Ph.D. — 7,267,292 for / 834,310 withheld (89.72% approval)
• Robert Philibert, M.D., Ph.D. — 7,266,486 for / 835,116 withheld (89.71% approval)
• Paul F. Burton, J.D., MBA — 7,466,218 for / 635,384 withheld (92.16% approval)
• Warren Hosseinion, M.D. — 6,215,891 for / 1,885,711 withheld (76.72% approval)
• James Intrater — 7,269,764 for / 831,838 withheld (89.73% approval)
• Wendy J. Betts — 7,314,250 for / 787,352 withheld (90.28% approval)
• Peter K. Fung, M.D. — 7,308,868 for / 792,734 withheld (90.22% approval)

• Reverse Stock Split Proposal — 9,825,603 for / 4,015,095 against / 275,450 abstain (69.63% approval) — passed
• Share Issuance Proposal — 5,617,556 for / 2,118,676 against / 365,370 abstain (70.97% approval) — passed
• Auditor Ratification Proposal — 12,010,406 for / 947,141 against / 1,158,601 abstain (85.10% approval) — passed